Post-infectious fatigue following Puumala virus infection

被引:10
作者
Furberg, Maria [1 ]
Anticona, Cynthia [2 ]
Schumann, Barbara [2 ]
机构
[1] Umea Univ, Dept Clin Microbiol, Umea, Sweden
[2] Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden
关键词
Puumala virus; nephropathia epidemica; post-infectious fatigue; recovery time; Northern Sweden; HEMORRHAGIC-FEVER; NEPHROPATHIA-EPIDEMICA; RENAL-SYNDROME; RISK; PROGNOSIS;
D O I
10.1080/23744235.2019.1605191
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Puumala virus infection or nephropathia epidemica (NE) is common in northern Sweden. NE causes haemorrhagic fever with renal syndrome. Most patients make a full recovery, but a convalescent phase with fatigue has been reported. Although post-infectious fatigue has been demonstrated for other viral infections, it is not well studied in relation to NE. This study assessed recovery time and levels of fatigue in former NE patients, as compared to the general population. Methods: NE patients diagnosed in northern Sweden between 2007 and 2011, together with a comparison sample from the general population, answered a questionnaire on demographic and health-related factors, including the Fatigue Severity Scale (FSS), and characteristics of NE infection. Self-reported recovery time was assessed, and fatigue levels were compared across the two groups by multiple linear regression, stratified by gender. Results: In total, 1132 NE patients and 915 comparison group subjects participated. Time to complete recovery was reported to exceed 3 months for 47% and 6 months for 32% of the NE patients. Recovery time differed by gender and age. NE patients had significantly higher FSS scores than the comparison group. Differences were greater among women than men, and adjustments for current illness, body mass index, smoking and current residence only slightly modified the estimates. Conclusions: Individuals with previous NE infection show higher fatigue scores than non-infected individuals, even 5 years following the infection. Full recovery takes half a year or longer for a substantial proportion of former NE patients.
引用
收藏
页码:519 / 526
页数:8
相关论文
共 27 条
[1]   PREVALENCE OF SERUM IGG ANTIBODIES TO PUUMALA VIRUS (HEMORRHAGIC-FEVER WITH RENAL-SYNDROME) IN NORTHERN SWEDEN [J].
AHLM, C ;
LINDERHOLM, M ;
JUTO, P ;
STEGMAYR, B ;
SETTERGREN, B .
EPIDEMIOLOGY AND INFECTION, 1994, 113 (01) :129-136
[2]   COMPARISON OF THE KINETICS OF PUUMALA VIRUS-SPECIFIC IGM AND IGG ANTIBODY-RESPONSES IN NEPHROPATHIA-EPIDEMICA AS MEASURED BY A RECOMBINANT ANTIGEN-BASED ENZYME-LINKED-IMMUNOSORBENT-ASSAY AND AN IMMUNOFLUORESCENCE TEST [J].
ELGH, F ;
WADELL, G ;
JUTO, P .
JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (02) :146-150
[3]  
Engberg I, 2017, BMC PUBLIC HLTH, V2014, P17, DOI DOI 10.1186/S12889-017-4623-Y
[4]  
Folkhalsomyndigheten Public Health Agency of Sweden, 2018, NOT DIS 2018
[5]   THE CHRONIC FATIGUE SYNDROME - A COMPREHENSIVE APPROACH TO ITS DEFINITION AND STUDY [J].
FUKUDA, K ;
STRAUS, SE ;
HICKIE, I ;
SHARPE, MC ;
DOBBINS, JG ;
KOMAROFF, A ;
SCHLUEDERBERG, A ;
JONES, JF ;
LLOYD, AR ;
WESSELY, S ;
GANTZ, NM ;
HOLMES, GP ;
BUCHWALD, D ;
ABBEY, S ;
REST, J ;
LEVY, JA ;
JOLSON, H ;
PETERSON, DL ;
VERCOULEN, JHMM ;
TIRELLI, U ;
EVENGARD, B ;
NATELSON, BH ;
STEELE, L ;
REYES, M ;
REEVES, WC .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (12) :953-959
[6]  
Gherasim Alin, 2015, Infection Ecology & Epidemiology, V5, P27698, DOI 10.3402/iee.v5.27698
[7]   Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study [J].
Hickie, Ian ;
Davenport, Trace ;
Wakefield, Denis ;
Vollmer-Conna, Ute ;
Cameron, Barbara ;
Vernon, Suzanne D. ;
Reeves, William C. ;
Lloyd, Andrew .
BRITISH MEDICAL JOURNAL, 2006, 333 (7568) :575-578
[8]   Mortality Rate Patterns for Hemorrhagic Fever with Renal Syndrome Caused by Puumala Virus [J].
Hjertqvist, Marika ;
Klein, Sabra L. ;
Ahlm, Clas ;
Klingstrom, Jonas .
EMERGING INFECTIOUS DISEASES, 2010, 16 (10) :1584-1586
[9]  
Klingstrom J., 2015, Sex and Gender Differences in Infection and Treatments for Infectious Diseases, P211
[10]  
LAHDEVIRTA J, 1971, ANN CLIN RES, V3, P1